The future of tumor vaccines in the post‐COVID‐19 era—Current challenges
Saved in:
| Main Author: | Panagiotis F. Christopoulos |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2021-12-01
|
| Series: | Immunity, Inflammation and Disease |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/iid3.521 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Body Mass Index and COVID-19: An Overview Among an Italian Multicentric Cohort of Healthcare Workers in the Pre- and Post-Vaccination Eras—ORCHESTRA Project
by: Gianluca Spiteri, et al.
Published: (2025-06-01) -
A vaccine is not too far for COVID-19
by: Shailesh Kumar Patel, et al.
Published: (2020-05-01) -
COVID-19 vaccination: challenges in the pediatric population
by: Alice Nicoleta Azoicai, et al.
Published: (2025-01-01) -
Innovations, Challenges, and Future Prospects for Combination Vaccines Against Human Infections
by: Munazza Fatima, et al.
Published: (2025-03-01) -
Influence of previous COVID-19 exposure and vaccine type (CoronaVac, ChAdOx1 nCov-19 or BNT162b2) on antibody and cytokine (Th1 or Th2) responses
by: Diana Lourdes Padilla-Bórquez, et al.
Published: (2024-12-01)